Local immune responses in tuberculosis

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1465-1474

  Ivanyi, Juraj ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952941597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50089-9     Document Type: Chapter

References (97)

1. -/- mice. J. Interferon Cytokine Res. 2001, 21(12):1089-1096.
2. Actor J.K., Olsen M., et al. Relationship of survival, organism containment, and granuloma formation in acute murine tuberculosis. J. Interferon Cytokine Res. 1999, 19(10):1183-1193.
3. Barnes P.F., Lu S., et al. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 1993, 61(8):3482-3489.
4. Bosio C.M., Gardner D., et al. Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology. J. Immunol. 2000, 164(12):6417-6425.
5. Brett S.J., Ivanyi J. Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology 1990, 71(1):113-119.
6. Brett S., Orrell J.M., et al. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 1992, 76(1):129-132.
7. Brown D.H., Miles B.A., et al. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: Establishment of latency and reactivation. Infect. Immun. 1995, 63(6):2243-2247.
8. Cardona P.J., Cooper A., et al. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand. J. Immunol. 1999, 49(4):362-366.
9. Cardona P.J., Llatjos R., et al. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand. J. Immunol. 2000, 52(2):156-163.
10. Chambers M.A., Williams A., et al. Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis. Infect. Immun. 2002, 70(4):2159-2165.
11. Chandramuki A., Lyashchenko K., et al. Detection of antibody to Mycobacterium tuberculosis protein antigens in the cerebrospinal fluid of patients with tuberculous meningitis. J. Infect. Dis. 2002, 186(5):678-683.
12. Chua-Intra B., Peerapakorn S., et al. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect. Immun. 1998, 66(10):4903-4909.
13. Costello A.M., Kumar A., et al. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?. Trans. R. Soc. Trop. Med. Hyg. 1992, 86(6):686-692.
14. Cox J.H., Knight B.C., et al. Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice. Infect. Immun. 1989, 57(6):1719-1724.
15. Cunningham A.F., Spreadbury C.L. Mycobacterial stationary phase induced by low oxygen tension: Cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J. Bacteriol. 1998, 180(4):801-808.
16. D'Souza C.D., Cooper A.M., et al. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to {itMycobacterium tuberculosis. J. Immunol. 1997, 158(3):1217-1221.
17. D'Souza C.D., Cooper A.M., et al. A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am. J. Respir. Cell Mol. Biol. 2000, 23(2):188-193.
18. Dieli F., Singh M., et al. Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand. J. Immunol. 2000, 52(1):96-102.
19. Dieli F., Sireci G., et al. Predominance of Vgamma9/Vdelta2 T lymphocytes in the cerebrospinal fluid of children with tuberculous meningitis: Reversal after chemotherapy. Mol. Med. 1999, 5(5):301-312.
20. Dieli F., Sireci G., et al. Ligand-specific alphabeta and gammadelta T cell responses in childhood tuberculosis. J. Infect. Dis. 2000, 181(1):294-301.
21. Dieli F., Ivanyi J., et al. Characterization of lung gammadelta T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 2003, 170(1):463-469.
22. Doherty T.M., Olsen A.W., et al. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 2002, 70(6):3111-3121.
23. Dunn P.L., North R.J. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 1995, 63(9):3428-3437.
24. Duque N., Gómez-Guerrero C., et al. Interaction of IgA with Fcα receptors of human mesangial cells activates transcription factor nuclear factorκB and induces expression and synthesis of monocyte chemoattractant protein-1, IL8 and IFN-inducible protein 10. J. Immunol. 1997, 159:3474-3482.
25. Edelson B.T., Unanue E.R. Intracellular antibody neutralizes Listeria growth. Immunity 2001, 14(5):503-512.
26. Falero-Diaz G., Challacombe S., et al. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine 2000, 18(28):3223-3229.
27. Falero-Diaz G., Challacombe S., et al. Transmission of IgA and IgG monoclonal antibodies to mucosal fluids following intranasal or parenteral delivery. Int. Arch. Allergy Immunol. 2000, 122(2):143-150.
28. Feng C.G., Britton W.J. CD4+ and CD8+ T cells mediate adoptive immunity to aerosol infection of Mycobacterium bovis bacillus Calmette-Guérin. J. Infect. Dis. 2000, 181(5):1846-1849.
29. Feng C.G., Britton W.J., et al. Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J. Immunol. 2000, 164(9):4853-4860.
30. Flesch I.E., Hess J.H., et al. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 1995, 181(5):1615-1621.
31. Flynn J.L., Goldstein M.M., et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 1995, 155(5):2515-2524.
32. Friscia G., Vordermeier H.M., et al. Human T cell responses to peptide epitopes of the 16-kD antigen in tuberculosis. Clin. Exp. Immunol. 1995, 102(1):53-57.
33. Garbe T.R., Hibler N.S., et al. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect. Immun. 1999, 67(1):460-465.
34. Glatman-Freedman A., Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 1998, 11(3):514-532.
35. Gonzalez-Juarrero M., Turner O.C., et al. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 2001, 69(3):1722-1728.
36. Gupta S., Kumari S., et al. Diagnostic utility of the estimation of mycobacterial Antigen A60 specific immunoglobulins IgM, IgA and IgG in the sera of cases of adult human tuberculosis. Tuber. Lung. Dis. 1995, 76(5):418-424.
37. Hellwig S.M., van Spriel A.B., et al. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect. Immun. 2001, 69(8):4846-4850.
38. Henderson R.A., Watkins S.C., et al. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997, 159(2):635-643.
39. Ivanyi J. Pathogenic and protective interactions in mycobacterial infections. Clinics in Immunology and Allergy 1986, 6:127-157.
40. Jacobs M., Fick L., et al. Enhanced immune response in Mycobacterium bovis bacille calmette guerin (BCG)-infected IL-10-deficient mice. Clin. Chem. Lab. Med. 2002, 40(9):893-902.
41. Jacobs M., Brown N., et al. Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin. Immunol. 2000, 94(3):192-199.
42. Jagannath C., Hoffmann H., et al. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol. 2000, 52(4):369-379.
43. Johansson U., Ivanyi J., et al. Inhibition of IL-12 production in human dendritic cells matured in the presence of Bacillus Calmette-Guerin or lipoarabinomannan. Immunol. Lett. 2001, 77(1):63-66.
44. Kakinuma M., Onoe K., et al. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages. Immunology 1983, 50(3):423-431.
45. Kasahara K., Sato I., et al. Expression of chemokines and induction of rapid cell death in human blood neutrophils by Mycobacterium tuberculosis. J. Infect. Dis. 1998, 178(1):127-137.
46. Kramnik I., Dietrich W.F., et al. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2000, 97:8560-8565. (15).
47. Lang R., Rutschman R.L., et al. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 2002, 168(7):3402-3411.
48. Lefford M.J. Induction and expression of immunity after BCG immunization. Infect. Immun. 1977, 18(3):646-653.
49. Lovik M., Closs O. Repeated delayed-type hypersensitivity reactions against Mycobacterium lepraemurium antigens at the infection site do not affect bacillary multiplication in C3H mice. Infect. Immun. 1982, 36(2):768-774.
50. Lyadova I.V., Vordermeier H.M., et al. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs. Clin. Exp. Immunol. 2001, 126(2):274-279.
51. Mackaness G.B. The immunology of antituberculous immunity. Am. Rev. Respir. Dis. 1968, 97(3):337-344.
52. Marshall B.G., Wangoo A., O'Gaora P., Cook H.T., Shaw R.J., Young D.B. Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide. Infect. Immun. 2001, 69:6676-6682.
53. Matsumoto H., Suzuki K., et al. Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells. Infect. Immun. 1997, 65(11):4405-4410.
54. McCune R.M., Feldmann F.M., et al. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 1966, 123(3):445-468.
55. Medina E., North R.J. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp 1 genotype. Immunology 1998, 93(2):270-274.
56. Mitsos L.M., Cardon L.R., et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes. Immun. 2000, 1(8):467-477.
57. Moreira A.L., Tsenova L., et al. Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect. Immun. 2002, 70(4):2100-2107.
58. Munk M.E., Mayer P., et al. Increased numbers of interleukin-12-producing cells in human tuberculosis. Infect. Immun. 1996, 64(3):1078-1080.
59. Murray P.J., Young R.A. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 1999, 67(6):3087-3095.
60. Musa S.A., Kim Y., et al. Response of inbred mice to aerosol challenge with Mycobacterium tuberculosis. Infect. Immun. 1987, 55(8):1862-1866.
61. North R.J. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis. 1995, 172(6):1550-1553.
62. North R.J. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 1998, 113(1):55-58.
63. North R.J., LaCourse R., et al. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice. Infect. Immun. 1999, 67(11):5811-5814.
64. Orrell J.M., Brett S.J., et al. Measurement of the immunoperoxidase staining of macrophages within liver granulomata of mice infected with Mycobacterium tuberculosis. Anal. Quant. Cytol. Histol. 1992, 14(6):451-458.
65. Orrell J.M., Brett S.J., et al. Morphometric analysis of Mycobacterium tuberculosis infection in mice suggests a genetic influence on the generation of the granulomatous inflammatory response. J. Pathol. 1992, 166(1):77-82.
66. Patry C., Sibille Y., et al. Identification of Fca receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J. Immunol. 1996, 156:4442-4448.
67. Pedrosa J., Saunders B.M., et al. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 2000, 68(2):577-583.
68. Pethe K., Alonso S., et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001, 412(6843):190-194.
69. Power C.A., Wei G., et al. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect. Immun. 1998, 66(12):5743-5750.
70. Raju B., Tung C.F., et al. In situ activation of helper T cells in the lung. Infect. Immun. 2001, 69(8):4790-4798.
71. Rees R.J. Enhanced susceptibility of thymectomized and irradiated mice to infection with Mycobacterium leprae. Nature 1966, 211(49):657-658.
72. Ridley M.J., Marianayagam Y., et al. Experimental granulomas induced by mycobacterial immune complexes in rats. J. Pathol. 1982, 136(1):59-72.
73. Roach D.R., Bean A.G., et al. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 2002, 168(9):4620-4627.
74. Roach D.R., Briscoe H., et al. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J. Exp. Med. 2001, 193(2):239-246.
75. Roach D.R., Martin E., et al. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 2001, 54(1-2):163-170.
76. Rodriguez A., et al. B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization. Vaccine 2003, 21(5-6):458-467.
77. Ruggeri F.M., Johansen K., et al. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J. Virol. 1998, 72(4):2708-2714.
78. Saunders B.M., Frank A.A., et al. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 1999, 98(3):324-328.
79. Saunders B.M., Frank A.A., et al. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 2000, 68(6):3322-3326.
80. Schrier D.J., Sternick J.L., et al. Immunogenetics of BCG-induced anergy in mice: control by genes linked to the Igh complex. J. Immunol. 1982, 128(3):1466-1469.
81. Skamene E., Schurr E., et al. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annu. Rev. Med. 1998, 49:275-287.
82. Smith S., Liggitt D., et al. Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect. Immun. 2002, 70(4):2082-2089.
83. Song C.H., Kim H.J., et al. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect. Immun. 2000, 68(8):4477-4484.
84. Stead W.W. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: Recrudescence of residuals of the primary infection or exogenous reinfection?. Am. Rev. Respir. Dis. 1967, 95(5):729-745.
85. Sugawara I., Yamada H., et al. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 1999, 67(5):2585-2589.
86. Surcel H.M., Troye-Blomberg M., et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994, 81(2):171-176.
87. Teitelbaum R., Glatman-Freedman A., et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA 1998, 95:15688-15693. (26).
88. Turner J., Frank A.A., et al. The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp. Gerontol. 2001, 36(3):537-545.
89. Turner J., Gonzalez-Juarrero M., et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 2002, 169(11):6343-6351.
90. Ueda K., Yamazaki S., et al. Spleen cell transfer induces T cell-dependent granulomas in tuberculous nude mice. J. Reticuloendothel. Soc. 1982, 31(6):469-478.
91. Venkataprasad N., Ledger P., et al. The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculous infection and in vitro superoxide anion production. Int. Arch. Allergy Immunol. 1997, 114(1):23-29.
92. Vordermeier H.M., Harris D.P., et al. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur. J. Immunol. 1992, 22(10):2631-2637.
93. Vordermeier H.M., Venkataprasad N., et al. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 1996, 106(2):312-316.
94. Wilkinson R.J., Vordermeier H.M., et al. Peptide-specific T cell response to Mycobacterium tuberculosis: Clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 1998, 178(3):760-768.
95. Williams A., R.A., et al. Passively transfered monoclonal IgA antibodies reduce tuberculous pulmonary infection in mice 2003, Submitted for Publication.
96. Winslow G.M., Yager E., et al. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect. Immun. 2000, 68(4):2187-2195.
97. Yang J., Mitsuyama M. An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice. Immunology 1997, 91(4):529-535.